In this pilot study on a small collection of 25 patients from routine diagnostics, a complete set of tumour biology data, including a protein assay of uPA and PAI-1 and a multigene test (OncotypeDX®), was analysed. The gene discussed is SERPINE1; the disease is neoplasm.